BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Drug Development

  Serentis Starts Phase II Trial with First-in-Class SRD441 for Eczema

  April 7, 2009

   · 

  1 min read
• Business

  XTL Biopharmaceuticals Ltd. Announces Financial Results for the Year Ended December 31, 2008

  April 7, 2009

   · 

  4 min read
• Pharm Country

  Sanofi-Aventis (France)'s Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States

  April 7, 2009

   · 

  8 min read
• Business

  Paradigm Medical Announces New President, Stephen Davis

  April 7, 2009

   · 

  2 min read
• Business

  I-many Reports Preliminary First Quarter 2009 Financial Results

  April 7, 2009

   · 

  6 min read
• Business

  Eli Lilly and Company Sets Date and Conference Call for First-Quarter 2009 Financial Results Announcement

  April 7, 2009

   · 

  1 min read
• Business

  ImmuneRegen BioSciences, Inc. Partners With University of Rochester Scientist to Explore Homspera(R) Activity Against Pulmonary Fibrosis

  April 7, 2009

   · 

  5 min read
• Policy

  Theravance, Inc. Announces FDA Acceptance of Telavancin NDA for the Treatment of Hospital-Acquired Pneumonia

  April 7, 2009

   · 

  6 min read
• Drug Development

  Ark Therapeutics Release: Cerepro(R) Phase III Trial Update

  April 7, 2009

   · 

  2 min read
• ReNeuron Release: Second Closing Of The Placing

  April 7, 2009

   · 

  2 min read